|
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 |
08/10/2015 |
CIM |
|
Glizigen® and Oncoxin®-Viusid® in cervical intraepithelial lesions of adult women. Phase II |
09/05/2018 |
CATALYSIS |
|
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory |
09/07/2018 |
CIM |
|
CIGB-Mambisa/Abdala in convalescents |
09/07/2021 |
CIGB |
|
Cuban uterine manipulator, new device for the hysterectomy totally laparoscopic. |
10/02/2017 |
CNCMA |
|
Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II |
10/05/2018 |
CATALYSIS |
|
CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. |
10/11/2014 |
CIGB |
|
Expanded Clinical Use of Nasalferon in COVID-19 |
10/11/2021 |
CIGB |
|
Phyisician Led CIMAvax-EGF lung biomarkers |
11/03/2021 |
CIM |
|
CIGB2020- ARI elderly contacts |
11/03/2021 |
CIGB |
|
DALIA Study |
11/08/2020 |
CIGB |
|
NeuroEPO-Stroke. Phase I-II |
11/09/2014 |
CIMAB |
|
Vitamin E/ Platinum salts |
12/05/2015 |
CIDEM |
|
NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer |
12/10/2016 |
CIM |
|
BACONAO Study |
12/11/2021 |
CIGB |
|
Community intrevention trial with VCN7-T in pediatric population, 2017-2021 (NeumoEfect) |
13/10/2017 |
FINLAY |
|
Melagenina Plus - Vitiligo – phase IV |
14/01/2019 |
CHP |
|
VALERGEN-combination of routes- Asthma-Adults-Phase II |
14/02/2019 |
BIOCEN |
|
COURAGE-2 Study |
14/03/2019 |
CIGB |
|
Safety and immunogenicity of the CIGB 2020. |
14/07/2020 |
CIGB |
